
Mary M. Lyons
Examiner (ID: 1163, Phone: (571)272-2966 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1653, 1645 |
| Total Applications | 662 |
| Issued Applications | 371 |
| Pending Applications | 93 |
| Abandoned Applications | 224 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19403934
[patent_doc_number] => 20240287445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => STREPTOMYCES ANTIBIOTICUS, PREPARATION OF METABOLITE THEREOF, AND USE THEREOF IN ANTIBACTERIAL ASPECT
[patent_app_type] => utility
[patent_app_number] => 18/549090
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549090
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549090 | STREPTOMYCES ANTIBIOTICUS, PREPARATION OF METABOLITE THEREOF, AND USE THEREOF IN ANTIBACTERIAL ASPECT | Oct 12, 2020 | Pending |
Array
(
[id] => 17518652
[patent_doc_number] => 20220104500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PSEUDOMONAS STRAINS AND THEIR METABOLITES TO CONTROL PLANT DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/063540
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063540 | None | Oct 4, 2020 | Issued |
Array
(
[id] => 18050705
[patent_doc_number] => 11524072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Vaccine delivery method
[patent_app_type] => utility
[patent_app_number] => 17/061696
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 64
[patent_no_of_words] => 17867
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061696
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061696 | Vaccine delivery method | Oct 1, 2020 | Issued |
Array
(
[id] => 17822711
[patent_doc_number] => 11427649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Haemorrhagic disorder due to ventricular assist device
[patent_app_type] => utility
[patent_app_number] => 17/061137
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 33
[patent_no_of_words] => 19054
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061137 | Haemorrhagic disorder due to ventricular assist device | Sep 30, 2020 | Issued |
Array
(
[id] => 16598058
[patent_doc_number] => 20210024589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => NEISSERIA MENINGITIDIS COMPOSITION AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/060067
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060067 | None | Sep 29, 2020 | Issued |
Array
(
[id] => 17981193
[patent_doc_number] => 20220347229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => STAPHYLOCOCCUS EPIDERMIDIS STRAIN HAVING IMMUNITY-ENHANCING ACTIVITY AND ANTIBACTERIAL ACTIVITY AGAINST PATHOGENIC BACTERIA, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/764799
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764799 | STAPHYLOCOCCUS EPIDERMIDIS STRAIN HAVING IMMUNITY-ENHANCING ACTIVITY AND ANTIBACTERIAL ACTIVITY AGAINST PATHOGENIC BACTERIA, AND USE THEREOF | Sep 28, 2020 | Pending |
Array
(
[id] => 18364863
[patent_doc_number] => 20230146454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => LACTOBACILLUS REUTERI
[patent_app_type] => utility
[patent_app_number] => 17/763542
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763542 | None | Sep 23, 2020 | Issued |
Array
(
[id] => 18229966
[patent_doc_number] => 20230068960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/638137
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638137 | Compositions and methods for treatment of inflammatory and immune diseases | Sep 23, 2020 | Issued |
Array
(
[id] => 17727748
[patent_doc_number] => 11384123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Mucoadhesive microorganism
[patent_app_type] => utility
[patent_app_number] => 17/026379
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 32247
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/026379 | Mucoadhesive microorganism | Sep 20, 2020 | Issued |
Array
(
[id] => 17975533
[patent_doc_number] => 11492381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Quantitative enzyme-linked immunoassay (ELISA) to approximate complement fixing antibody titers in serum from patients with coccidioidomycosis
[patent_app_type] => utility
[patent_app_number] => 17/023133
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 8687
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/023133 | Quantitative enzyme-linked immunoassay (ELISA) to approximate complement fixing antibody titers in serum from patients with coccidioidomycosis | Sep 15, 2020 | Issued |
Array
(
[id] => 16539434
[patent_doc_number] => 20200405847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Pro-Inflammatory and Adjuvant Functions of Toll-Like Receptor 4 Antagonists
[patent_app_type] => utility
[patent_app_number] => 17/018038
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018038 | Pro-inflammatory and adjuvant functions of toll-like receptor 4 antagonists | Sep 10, 2020 | Issued |
Array
(
[id] => 17911353
[patent_doc_number] => 20220313748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF HPV-RELATED CANCER
[patent_app_type] => utility
[patent_app_number] => 17/642654
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642654
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642654 | Methods and compositions for the treatment of HPV-related cancer | Sep 10, 2020 | Issued |
Array
(
[id] => 17648547
[patent_doc_number] => 11351250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Pro-inflammatory and anti-cancer functions of toll-like receptor 4 antagonists
[patent_app_type] => utility
[patent_app_number] => 17/018045
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 23266
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018045 | Pro-inflammatory and anti-cancer functions of toll-like receptor 4 antagonists | Sep 10, 2020 | Issued |
Array
(
[id] => 18341279
[patent_doc_number] => 11638748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Pathogen vaccines and methods of producing and using the same
[patent_app_type] => utility
[patent_app_number] => 17/015177
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 33
[patent_no_of_words] => 34005
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/015177 | Pathogen vaccines and methods of producing and using the same | Sep 8, 2020 | Issued |
Array
(
[id] => 16539424
[patent_doc_number] => 20200405837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/000590
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17000590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/000590 | IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | Aug 23, 2020 | Abandoned |
Array
(
[id] => 16735885
[patent_doc_number] => 10961523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Multilayer nano-cell
[patent_app_type] => utility
[patent_app_number] => 16/996457
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13844
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996457 | Multilayer nano-cell | Aug 17, 2020 | Issued |
Array
(
[id] => 16657396
[patent_doc_number] => 20210054032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
[patent_app_type] => utility
[patent_app_number] => 16/990023
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990023 | Mutant fragments of OspA and methods and uses relating thereto | Aug 10, 2020 | Issued |
Array
(
[id] => 16688709
[patent_doc_number] => 20210071185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => METHOD AND SYSTEM FOR TERPENE PRODUCTION PLATFORMS IN YEAST
[patent_app_type] => utility
[patent_app_number] => 16/990802
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990802 | Method and system for terpene production platforms in yeast | Aug 10, 2020 | Issued |
Array
(
[id] => 17712344
[patent_doc_number] => 11376323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Mixtures of polysaccharide protein pegylated compounds
[patent_app_type] => utility
[patent_app_number] => 16/984145
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 9209
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984145 | Mixtures of polysaccharide protein pegylated compounds | Aug 2, 2020 | Issued |
Array
(
[id] => 16688683
[patent_doc_number] => 20210071159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => TUNING MICROBIAL POPULATIONS WITH PROGRAMMABLE NUCLEASES
[patent_app_type] => utility
[patent_app_number] => 16/936881
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936881
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936881 | TUNING MICROBIAL POPULATIONS WITH PROGRAMMABLE NUCLEASES | Jul 22, 2020 | Abandoned |